169 related articles for article (PubMed ID: 12085243)
1. Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.
Patterson AV; Williams KJ; Cowen RL; Jaffar M; Telfer BA; Saunders M; Airley R; Honess D; van der Kogel AJ; Wolf CR; Stratford IJ
Gene Ther; 2002 Jul; 9(14):946-54. PubMed ID: 12085243
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure.
Cowen RL; Williams KJ; Chinje EC; Jaffar M; Sheppard FC; Telfer BA; Wind NS; Stratford IJ
Cancer Res; 2004 Feb; 64(4):1396-402. PubMed ID: 14973055
[TBL] [Abstract][Full Text] [Related]
3. A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N.
McErlane V; Yakkundi A; McCarthy HO; Hughes CM; Patterson LH; Hirst DG; Robson T; McKeown SR
J Gene Med; 2005 Jul; 7(7):851-9. PubMed ID: 15712360
[TBL] [Abstract][Full Text] [Related]
4. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
[TBL] [Abstract][Full Text] [Related]
5. Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.
Cowen RL; Patterson AV; Telfer BA; Airley RE; Hobbs S; Phillips RM; Jaffar M; Stratford IJ; Williams KJ
Mol Cancer Ther; 2003 Sep; 2(9):901-9. PubMed ID: 14555709
[TBL] [Abstract][Full Text] [Related]
6. Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
McCarthy HO; Yakkundi A; McErlane V; Hughes CM; Keilty G; Murray M; Patterson LH; Hirst DG; McKeown SR; Robson T
Cancer Gene Ther; 2003 Jan; 10(1):40-8. PubMed ID: 12489027
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified macrophages expressing hypoxia regulated cytochrome P450 and P450 reductase for the treatment of cancer.
Kan O; Day D; Iqball S; Burke F; Grimshaw MJ; Naylor S; Binley K
Int J Mol Med; 2011 Feb; 27(2):173-80. PubMed ID: 21165551
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements.
Wang WD; Chen ZT; Li R; Li DZ; Duan YZ; Cao ZH
Cancer Sci; 2005 Dec; 96(12):918-24. PubMed ID: 16367913
[TBL] [Abstract][Full Text] [Related]
9. Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.
Bremner JC
Cancer Metastasis Rev; 1993 Jun; 12(2):177-93. PubMed ID: 8375020
[TBL] [Abstract][Full Text] [Related]
10. Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2004 Jan; 64(1):292-303. PubMed ID: 14729637
[TBL] [Abstract][Full Text] [Related]
11. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Holden SA; Teicher BA; Herman TS
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
[TBL] [Abstract][Full Text] [Related]
12. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
[TBL] [Abstract][Full Text] [Related]
15. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
16. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
[TBL] [Abstract][Full Text] [Related]
17. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.
Shibata T; Giaccia AJ; Brown JM
Neoplasia; 2002; 4(1):40-8. PubMed ID: 11922390
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069.
Cole S; Robbins L
Radiother Oncol; 1989 Nov; 16(3):235-43. PubMed ID: 2587812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
